• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53结构域:两个自主DNA结合区域的鉴定与表征

p53 domains: identification and characterization of two autonomous DNA-binding regions.

作者信息

Wang Y, Reed M, Wang P, Stenger J E, Mayr G, Anderson M E, Schwedes J F, Tegtmeyer P

机构信息

Department of Microbiology, State University of New York, Stony Brook 11794.

出版信息

Genes Dev. 1993 Dec;7(12B):2575-86. doi: 10.1101/gad.7.12b.2575.

DOI:10.1101/gad.7.12b.2575
PMID:8276240
Abstract

We have investigated the DNA-binding, oligomerization, and trans-activation functions of isolated segments of murine p53. We find that p53 has two autonomous DNA-binding regions. One domain, from amino acid 280 to 390, forms stable tetramers and binds DNA nonspecifically. The biological significance, if any, of this DNA-binding activity is not known. A second domain, from amino acid 80 to 290, does not form stable tetramers under stringent conditions but binds DNA both specifically and nonspecifically. The specific DNA-binding function of p53, therefore, resides in the highly conserved central region of the protein and does not require stable tetramerization. Amino acids 1-290, which include both the specific DNA-binding domain and the amino-terminal acidic region, activate a p53-specific promoter in vivo. This finding strongly argues that the DNA-binding activity of p53 segment 80-290 is physiologically significant. The role of tetramerization in p53 function remains to be determined.

摘要

我们研究了小鼠p53分离片段的DNA结合、寡聚化及反式激活功能。我们发现p53有两个自主的DNA结合区域。一个结构域,从氨基酸280至390,形成稳定的四聚体并非特异性地结合DNA。这种DNA结合活性的生物学意义(如果有的话)尚不清楚。第二个结构域,从氨基酸80至290,在严格条件下不形成稳定的四聚体,但能特异性和非特异性地结合DNA。因此,p53的特异性DNA结合功能位于蛋白质高度保守的中心区域,且不需要稳定的四聚化。包括特异性DNA结合结构域和氨基末端酸性区域的氨基酸1 - 290在体内激活p53特异性启动子。这一发现有力地表明p53片段80 - 290的DNA结合活性具有生理意义。四聚化在p53功能中的作用仍有待确定。

相似文献

1
p53 domains: identification and characterization of two autonomous DNA-binding regions.p53结构域:两个自主DNA结合区域的鉴定与表征
Genes Dev. 1993 Dec;7(12B):2575-86. doi: 10.1101/gad.7.12b.2575.
2
Interaction of p53 with its consensus DNA-binding site.p53与其共有DNA结合位点的相互作用。
Mol Cell Biol. 1995 Apr;15(4):2157-65. doi: 10.1128/MCB.15.4.2157.
3
p53 domains: structure, oligomerization, and transformation.p53结构域:结构、寡聚化及转化
Mol Cell Biol. 1994 Aug;14(8):5182-91. doi: 10.1128/mcb.14.8.5182-5191.1994.
4
The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.p53的C末端结构域可识别因电离辐射而受损的DNA。
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9455-9. doi: 10.1073/pnas.92.21.9455.
5
p53 oligomerization and DNA looping are linked with transcriptional activation.p53寡聚化和DNA环化与转录激活相关联。
EMBO J. 1994 Dec 15;13(24):6011-20. doi: 10.1002/j.1460-2075.1994.tb06947.x.
6
The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.p53蛋白的羧基末端结构域通过其非特异性核酸结合活性调节序列特异性DNA结合。
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5729-33. doi: 10.1073/pnas.92.12.5729.
7
A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.当从野生型p53蛋白而非致癌性突变型p53蛋白产生时,来自p53中央区域的蛋白水解片段具有显著的序列特异性DNA结合活性。
Genes Dev. 1993 Dec;7(12B):2565-74. doi: 10.1101/gad.7.12b.2565.
8
DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.p53在包括新位点Ser20在内的N端位点的DNA损伤诱导磷酸化需要四聚化。
EMBO J. 1999 Apr 1;18(7):1815-23. doi: 10.1093/emboj/18.7.1815.
9
The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.p53的DNA结合结构域包含四个保守区域和主要的突变热点。
Genes Dev. 1993 Dec;7(12B):2556-64. doi: 10.1101/gad.7.12b.2556.
10
Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.p53 蛋白 DNA 结合结构域内源自肿瘤的突变,其表型类似于富含脯氨酸结构域的缺失。
Oncogene. 2000 Mar 30;19(14):1834-42. doi: 10.1038/sj.onc.1203500.

引用本文的文献

1
Exploring the Functional Landscape of the p53 Regulatory Domain: The Stabilizing Role of Post-Translational Modifications.探索 p53 调控域的功能景观:翻译后修饰的稳定作用。
J Chem Theory Comput. 2024 Jul 23;20(14):5842-5853. doi: 10.1021/acs.jctc.4c00570. Epub 2024 Jul 7.
2
Therapeutic Strategies to Activate p53.激活p53的治疗策略
Pharmaceuticals (Basel). 2022 Dec 24;16(1):24. doi: 10.3390/ph16010024.
3
The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
p53 的 C 末端结构域协调 PARP1 通过非共价和共价聚(ADP-核糖基)化 p53 之间的相互作用。
Nucleic Acids Res. 2018 Jan 25;46(2):804-822. doi: 10.1093/nar/gkx1205.
4
Reviving the guardian of the genome: Small molecule activators of p53.唤醒基因组的守护者:p53 的小分子激活剂。
Pharmacol Ther. 2017 Oct;178:92-108. doi: 10.1016/j.pharmthera.2017.03.013. Epub 2017 Mar 27.
5
Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?错误折叠的肿瘤抑制因子的聚集及类朊病毒特性:癌症是一种朊病毒病吗?
Cold Spring Harb Perspect Biol. 2016 Oct 3;8(10):a023614. doi: 10.1101/cshperspect.a023614.
6
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.人类癌症中c-Abl和p53的错误折叠、聚集及无序片段
Front Oncol. 2015 Apr 29;5:97. doi: 10.3389/fonc.2015.00097. eCollection 2015.
7
Targeting tumor suppressor networks for cancer therapeutics.针对肿瘤抑制网络的癌症治疗策略。
Curr Drug Targets. 2014 Jan;15(1):2-16. doi: 10.2174/1389450114666140106095151.
8
Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.针对 p53 的泛素介导的蛋白酶体降解进行癌症治疗。
Curr Pharm Des. 2013;19(18):3248-62. doi: 10.2174/1381612811319180009.
9
p53 is an important regulator of CCL2 gene expression.p53 是 CCL2 基因表达的重要调节因子。
Curr Mol Med. 2012 Sep;12(8):929-43. doi: 10.2174/156652412802480844.
10
Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21.乙型肝炎病毒核心启动子突变通过下调 SKP2 及其靶标 p21 促进肝癌发生。
Gastroenterology. 2011 Oct;141(4):1412-21, 1421.e1-5. doi: 10.1053/j.gastro.2011.06.048. Epub 2011 Jun 24.